Peter Silverman

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Yarrow Bioscience, Inc. publishes a filing, an earnings call transcript or a press release.

Get YARW alerts

About Peter Silverman

Peter Silverman is recorded as Board Member at Yarrow Bioscience, Inc. (YARW) since July 27, 2026. Yarrow Bioscience, Inc. reported in an 8-K filed July 28, 2026 that Peter Silverman was appointed Class III director, effective July 27, 2026. Yarrow Bioscience, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Yarrow Bioscience, Inc. includes Rebecca Frey (CEO and Board Member), Bill Lundberg (Chairman and Board Member), Andrew Saik (CFO) and 7 others.

“On July 27, 2026, the Board set its size at six members and appointed the following six individuals to the Board: Rebecca Frey, Mona Ashiya, Steven Hoerter, Bill Lundberg, Peter Silverman and William White.”

Yarrow Bioscience, Inc. Form 8-K, filed July 28, 2026 · Read the filing

Affiliation history

Yarrow Bioscience, Inc. (YARW)
Board Member

SEC 8-K

Current
2026-07-27–present

Company network

Yarrow Bioscience, Inc.

YARW

Current role

Biotechnology · Healthcare

Board Member

2026-07-27–present

Leadership on record at Yarrow Bioscience, Inc.

Rebecca Frey CEO, Board Member
Bill Lundberg Chairman, Board Member
Andrew Saik CFO
Ilan Hadar CFO
Tyler Zeronda CFO
Rachael Alford COO
Iain Stuart CTO
David Domzalski Board Member
Dr. Christine Borowski Board Member
Mona Ashiya Board Member

Recent activity

Executive change Appointed: Class III director Yarrow Bioscience, Inc. (YARW)
2026-07-27